feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Delhi air quality very poor

trending

Fire at Baby Memorial Hospital

trending

Ayan Mukerji directs Ranbir, Deepika

trending

Manisha Koirala stuns in saree

trending

Kohli, Rohit for 2027 worldcup

trending

Kerala Karunya KR-732 result

trending

IBPS Clerk Mains exam timings

trending

IBM AI tackles languages

trending

Airbus A320 software update ordered

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Business and Economy / Guardian Pharmacy Surges on Robust Q3 Earnings

Guardian Pharmacy Surges on Robust Q3 Earnings

14 Nov

•

Summary

  • Guardian Pharmacy's Q3 revenue and earnings top estimates
  • Company serves over 204,000 residents across 8,200 long-term care facilities
  • Guardian aims to become the nation's leading long-term care pharmacy provider
Guardian Pharmacy Surges on Robust Q3 Earnings

On November 14, 2025, Guardian Pharmacy Services, a small-cap healthcare company, made headlines with its impressive third-quarter financial results. The $1.98 billion company, which had been consolidating for months, broke decisively higher following the release of its earnings report.

Guardian Pharmacy Services is a leading provider of technology-driven pharmacy management solutions for long-term care facilities across the United States. The company's mission is to promote health and wellness for older adults and those with complex care needs, while easing operational burdens for caregivers. As of November 2025, Guardian operates a network of over 53 pharmacies serving more than 204,000 residents across 8,200 long-term care facilities in 38 states.

Guardian's latest quarterly results exceeded expectations across the board. The company reported revenue of $377 million, easily beating analyst estimates of $354 million, and earnings per share (EPS) of 25 cents, one cent above consensus. Year-over-year, Guardian's revenue rose 20%, driven by a 13% increase in total residents served, a key growth metric that underscores the company's expanding reach and growing demand for its pharmacy solutions.

This strong performance has put Guardian Pharmacy Services on the radar of both traders and long-term investors, as the company continues to solidify its position as a leading player in the long-term care pharmacy services market.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Guardian Pharmacy Services' mission is to promote health and wellness for older adults and those with complex care needs, while easing operational burdens for caregivers.
As of November 2025, Guardian Pharmacy Services operates a network of over 53 pharmacies serving more than 204,000 residents across 8,200 long-term care facilities in 38 states.
Guardian Pharmacy Services reported revenue of $377 million, easily beating analyst estimates of $354 million, and earnings per share (EPS) of 25 cents, one cent above consensus. Year-over-year, the company's revenue rose 20%.

Read more news on

Business and Economyside-arrowUnited Statesside-arrow

You may also like

Merck Stock Surges on Wells Fargo Upgrade

1 day ago • 3 reads

article image

Walgreens Nasal Spray Recalled: Potential Bacteria Risk

27 Nov • 8 reads

article image

Costco Vaccines: Savings or Scams?

26 Nov • 9 reads

article image

Bayer Stroke Drug Trial Shows Promise

24 Nov • 25 reads

article image

Experts Criticize FDA for Baseless Hormone Therapy Claims

24 Nov • 20 reads

article image